Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$247
2 trades · 1 insiders
Net · 90d
$-247
Insiders on file
9
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Duhay Francis | Director | 13 | $297.6K | $9.1K | 2026-09-11 |
| Alavi Hamed | Chief Technology Officer | 6 | $0 | $51.8K | 2025-12-16 |
| Glickman Marc H. | SVP & Chief Medical Officer | 5 | $0 | $0 | 2025-12-16 |
| BERMAN ROBERT ANDREW | Chief Executive Officer | 9 | $70.7K | $0 | 2025-12-16 |
| Gray Robert | Director | 8 | $10.3K | $0 | 2025-12-11 |
| Shrivastava Sanjay | Director | 9 | $19.5K | $0 | 2025-12-11 |
| Jenusaitis Matthew | Director | 8 | $24.3K | $0 | 2025-12-11 |
| Bright Jennifer | Chief Financial Officer | 1 | $0 | $0 | 2025-05-19 |
| Glynn Craig | Chief Financial Officer | 3 | $0 | $0 | 2023-12-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Duhay Francis | Director | S Sale | 2026-09-11 | 2026-09-14 | 11 | $11.21 | $123 | 2,351 | SEC↗ |
| Duhay Francis | Director | S Sale | 2026-09-11 | 2026-09-14 | 11 | $11.21 | $123 | 2,351 | SEC↗ |
| Duhay Francis | Director | S Sale | 2026-06-11 | 2026-06-12 | 140 | $10.31 | $1.4K | 2,362 | SEC↗ |
| Duhay Francis | Director | S Sale | 2026-03-12 | 2026-03-13 | 140 | $11.52 | $1.6K | 2,502 | SEC↗ |
| Glickman Marc H. | SVP & Chief Medical Officer | J Other deriv | 2025-12-16 | 2025-12-18 | 100,000 | — | $0 | 0 | SEC↗ |
| Alavi Hamed | Chief Technology Officer | J Other deriv | 2025-12-16 | 2025-12-18 | 50,000 | — | $0 | 0 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | J Other deriv | 2025-12-16 | 2025-12-18 | 200,000 | — | $0 | 0 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 135,883 | — | $0 | 135,883 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 135,883 | — | $0 | 135,883 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 135,883 | — | $0 | 135,883 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2025-12-11 | 2025-12-15 | 135,883 | — | $0 | 135,883 | SEC↗ |
| Duhay Francis | Director | S Sale | 2025-12-11 | 2025-12-12 | 4,900 | $0.36 | $1.8K | 92,544 | SEC↗ |
| Duhay Francis | Director | S Sale | 2025-09-15 | 2025-09-17 | 4,900 | $0.83 | $4.1K | 97,444 | SEC↗ |
| Bright Jennifer | Chief Financial Officer | A Award deriv | 2025-05-19 | 2025-05-20 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Gray Robert | Director | P Buy | 2024-12-31 | 2025-01-02 | 3,500 | $2.94 | $10.3K | 11,155 | SEC↗ |
| Duhay Francis | Director | P Buy | 2024-12-31 | 2025-01-03 | 81,433 | $3.07 | $250.0K | 102,344 | SEC↗ |
| Shrivastava Sanjay | Director | P Buy | 2024-12-24 | 2024-12-26 | 5,400 | $2.90 | $15.7K | 9,288 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | P Buy | 2024-12-19 | 2024-12-19 | 12,000 | $2.55 | $30.6K | 222,236 | SEC↗ |
| Jenusaitis Matthew | Director | P Buy | 2024-12-19 | 2024-12-23 | 9,620 | $2.53 | $24.3K | 16,545 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2024-12-18 | 2024-12-20 | 19,752 | — | $0 | 19,752 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | A Award deriv | 2024-12-18 | 2024-12-20 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Alavi Hamed | Chief Technology Officer | A Award deriv | 2024-12-18 | 2024-12-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2024-12-18 | 2024-12-20 | 19,752 | — | $0 | 19,752 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2024-12-18 | 2024-12-20 | 19,752 | — | $0 | 19,752 | SEC↗ |
| Glickman Marc H. | SVP & Chief Medical Officer | A Award deriv | 2024-12-18 | 2024-12-20 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2024-12-18 | 2024-12-20 | 19,752 | — | $0 | 19,752 | SEC↗ |
| Alavi Hamed | Chief Technology Officer | M Exercise deriv | 2024-03-13 | 2024-03-15 | 8,334 | — | $0 | 91,666 | SEC↗ |
| Alavi Hamed | Chief Technology Officer | M Exercise | 2024-03-13 | 2024-03-15 | 8,334 | $3.59 | $29.9K | 8,334 | SEC↗ |
| Alavi Hamed | Chief Technology Officer | S Sale | 2024-03-13 | 2024-03-15 | 8,334 | $6.22 | $51.8K | 0 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2023-12-05 | 2023-12-07 | 13,856 | — | $0 | 13,856 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2023-12-05 | 2023-12-07 | 13,856 | — | $0 | 13,856 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | A Award deriv | 2023-12-05 | 2023-12-07 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Glickman Marc H. | SVP & Chief Medical Officer | A Award deriv | 2023-12-05 | 2023-12-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Alavi Hamed | Chief Technology Officer | A Award deriv | 2023-12-05 | 2023-12-07 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2023-12-05 | 2023-12-07 | 13,856 | — | $0 | 13,856 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2023-12-05 | 2023-12-07 | 13,856 | — | $0 | 13,856 | SEC↗ |
| Glynn Craig | Chief Financial Officer | A Award deriv | 2023-12-05 | 2023-12-07 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2022-11-30 | 2022-12-02 | 8,403 | — | $0 | 8,403 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2022-11-30 | 2022-12-02 | 8,403 | — | $0 | 8,403 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2022-11-30 | 2022-12-02 | 8,403 | — | $0 | 8,403 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2022-11-30 | 2022-12-02 | 8,403 | — | $0 | 8,403 | SEC↗ |
| Jenusaitis Matthew | Director | M Exercise deriv | 2022-09-13 | 2022-09-16 | 1,041 | — | $0 | 0 | SEC↗ |
| Gray Robert | Director | M Exercise deriv | 2022-09-13 | 2022-09-16 | 1,041 | — | $0 | 0 | SEC↗ |
| Jenusaitis Matthew | Director | M Exercise | 2022-09-13 | 2022-09-16 | 1,041 | — | $0 | 6,925 | SEC↗ |
| Gray Robert | Director | M Exercise | 2022-09-13 | 2022-09-16 | 1,041 | — | $0 | 7,655 | SEC↗ |
| Duhay Francis | Director | P Buy | 2022-08-16 | 2022-08-18 | 7,751 | $6.14 | $47.6K | 20,911 | SEC↗ |
| Shrivastava Sanjay | Director | P Buy | 2022-06-30 | 2022-07-01 | 1,000 | $3.85 | $3.9K | 3,888 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | P Buy | 2022-06-27 | 2022-06-28 | 2,500 | $3.80 | $9.5K | 210,236 | SEC↗ |
| Shrivastava Sanjay | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 7,211 | — | $0 | 7,211 | SEC↗ |
| Jenusaitis Matthew | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 7,211 | — | $0 | 7,211 | SEC↗ |
| Duhay Francis | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 7,211 | — | $0 | 7,211 | SEC↗ |
| Gray Robert | Director | A Award deriv | 2021-11-30 | 2021-12-02 | 7,211 | — | $0 | 7,211 | SEC↗ |
| Glynn Craig | Chief Financial Officer | A Award deriv | 2021-11-30 | 2021-12-02 | 125,925 | — | $0 | 125,925 | SEC↗ |
| Glickman Marc H. | SVP & Chief Medical Officer | A Award deriv | 2021-11-30 | 2021-12-02 | 265,700 | — | $0 | 265,700 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | A Award deriv | 2021-11-30 | 2021-12-02 | 349,781 | — | $0 | 349,781 | SEC↗ |
| Glynn Craig | Chief Financial Officer | A Award | 2021-11-30 | 2021-12-02 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Glickman Marc H. | SVP & Chief Medical Officer | A Award | 2021-11-30 | 2021-12-02 | 100,000 | — | $0 | 101,600 | SEC↗ |
| BERMAN ROBERT ANDREW | Chief Executive Officer | A Award | 2021-11-30 | 2021-12-02 | 200,000 | — | $0 | 207,736 | SEC↗ |
| BERMAN ROBERT ANDREW | CEO | P Buy | 2021-11-19 | 2021-11-19 | 2,000 | $7.43 | $14.9K | 7,736 | SEC↗ |
| Shrivastava Sanjay | Director | M Exercise deriv | 2021-11-16 | 2021-11-18 | 388 | — | $0 | 0 | SEC↗ |
| BERMAN ROBERT ANDREW | CEO | P Buy | 2021-11-16 | 2021-11-18 | 2,000 | $7.87 | $15.7K | 5,736 | SEC↗ |
| Shrivastava Sanjay | Director | M Exercise | 2021-11-16 | 2021-11-18 | 388 | — | $0 | 2,888 | SEC↗ |